iShares Biotechnology ETF Rating → Shocking $16T Elon Musk Crypto Leak (From Crypto 101 Media) (Ad) Free IBB Stock Alerts $136.69 -0.60 (-0.44%) (As of 05/17/2024 ET) Add Compare Share Share RatingsStock AnalysisChartDividendHeadlinesHoldingsOptions ChainOwnershipRatingsSEC FilingsShort InterestSocial MediaStock AnalysisChartDividendHeadlinesHoldingsOptions ChainOwnershipRatingsSEC FilingsShort InterestSocial Media iShares Biotechnology ETF Aggregate Rating and Price Target (2024)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.IBB Aggregate RatingModerate Buy2.57Holdings in IBB have an aggregate rating of Moderate Buy based on 664 analyst ratings issued in the past year covering 50 companies (84.1% of the portfolio).IBB Aggregate Price Target$158.1315.69% UpsideHigh Prediction$207.67Average Prediction$158.13Low Prediction$114.84Holdings in IBB have an aggregate price target of $158.13 and a range of $114.84 to $207.67 covering 50 companies (84.1% of the portfolio).IBB Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy6 Buy rating(s)Moderate Buy32 Moderate Buy rating(s)Hold11 Hold rating(s)Reduce1 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by iShares Biotechnology ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 50 IBB Holdings Export to ExcelWeightIn ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings8.62%AMGNAmgen$312.47-0.7%5 of 5 stars2.52$305.65 -2.2%21Options Volume8.22%REGNRegeneron Pharmaceuticals$982.29+1.5%4 of 5 stars2.76$989.36 0.7%21Analyst ForecastInsider SellingNews Coverage8.06%VRTXVertex Pharmaceuticals$445.21+1.0%4 of 5 stars2.48$432.18 -2.9%257.68%GILDGilead Sciences$67.72-0.2%5 of 5 stars2.35$83.69 23.6%174.34%MRNAModerna$132.90+0.2%3 of 5 stars2.24$126.46 -4.8%17Analyst ForecastInsider Selling4.11%IQVIQVIA$231.18-1.6%5 of 5 stars2.80$257.57 11.4%153.18%BIIBBiogen$230.57+0.2%5 of 5 stars2.65$288.46 25.1%26Analyst ForecastNews Coverage2.73%MTDMettler-Toledo International$1,522.75-0.5%4 of 5 stars2.14$1,257.14 -17.4%7Insider SellingNews Coverage2.04%ARGXargenx$365.81-2.9%3 of 5 stars2.71$524.68 43.4%21Earnings ReportShort Interest ↑2.02%ILMNIllumina$111.07-3.0%5 of 5 stars2.30$164.65 48.2%20Short Interest ↓1.97%BNTXBioNTech$90.61-2.5%1 of 5 stars2.20$111.70 23.3%10Analyst ForecastShort Interest ↑1.94%ALNYAlnylam Pharmaceuticals$149.40-1.2%5 of 5 stars2.59$216.19 44.7%17Short Interest ↑1.92%WATWaters$355.95-1.3%3 of 5 stars1.90$305.78 -14.1%10Insider Selling1.61%GMABGenmab A/S$29.98+1.1%3 of 5 stars2.38$48.50 61.8%13Positive News1.60%BMRNBioMarin Pharmaceutical$77.56+0.8%5 of 5 stars2.60$106.11 36.8%21Analyst ForecastShort Interest ↑Analyst Revision1.40%NBIXNeurocrine Biosciences$142.29+0.3%5 of 5 stars2.79$148.96 4.7%24Analyst ForecastInsider Selling1.35%BGNEBeiGene$172.85+1.1%3 of 5 stars2.80$251.93 45.8%10Positive News1.21%INCYIncyte$57.10+0.4%5 of 5 stars2.47$74.93 31.2%17Short Interest ↑1.21%TECHBio-Techne$83.81+1.2%4 of 5 stars2.82$80.50 -3.9%11Positive News1.19%CRLCharles River Laboratories International$221.61-1.4%5 of 5 stars2.64$255.27 15.2%11Analyst UpgradeInsider Selling1.19%SRPTSarepta Therapeutics$131.38-1.0%5 of 5 stars2.86$163.94 24.8%14Analyst UpgradePositive News1.15%UTHRUnited Therapeutics$274.26+0.7%5 of 5 stars2.90$308.78 12.6%10Analyst UpgradeInsider Selling1.07%NTRANatera$106.46-1.9%1 of 5 stars3.00$98.47 -7.5%15Analyst ForecastInsider SellingNews Coverage0.99%MEDPMedpace$393.30+0.0%5 of 5 stars2.80$443.00 12.6%5Analyst RevisionPositive News0.89%RGENRepligen$171.94+0.5%4 of 5 stars2.89$197.75 15.0%9Positive News0.73%LEGNLegend Biotech$45.16-2.6%2 of 5 stars2.92$82.74 83.2%12Earnings ReportAnalyst ForecastAnalyst Revision0.70%ASNDAscendis Pharma A/S$121.12-1.4%1 of 5 stars2.88$176.88 46.0%8Analyst ForecastNews Coverage0.68%PCVXVaxcyte$74.57-1.2%0 of 5 stars3.00$78.50 5.3%40.68%ITCIIntra-Cellular Therapies$65.00-2.3%5 of 5 stars2.90$90.17 38.7%10Positive News0.67%EXELExelixis$20.91-1.5%5 of 5 stars2.59$26.13 24.9%17Analyst ForecastInsider SellingShort Interest ↑0.66%BPMCBlueprint Medicines$104.96-1.6%1 of 5 stars2.53$102.65 -2.2%17Analyst ForecastShort Interest ↑Analyst Revision0.66%CYTKCytokinetics$59.53-0.7%4 of 5 stars2.87$81.60 37.1%15Analyst Forecast0.65%BRKRBruker$75.07-1.0%5 of 5 stars2.43$84.86 13.0%7Dividend AnnouncementAnalyst RevisionNews Coverage0.59%IONSIonis Pharmaceuticals$37.31-0.8%5 of 5 stars2.71$59.54 59.6%14Short Interest ↓News Coverage0.56%ROIVRoivant Sciences$11.23-1.6%2 of 5 stars2.90$16.90 50.5%10News CoveragePositive News0.55%RVMDRevolution Medicines$39.41+1.1%3 of 5 stars3.10$43.20 9.6%10Analyst Revision0.52%HALOHalozyme Therapeutics$44.71-1.5%5 of 5 stars2.83$53.14 18.9%6Positive News0.48%APLSApellis Pharmaceuticals$41.31-1.6%5 of 5 stars2.87$76.67 85.6%15Options VolumeAnalyst Revision0.45%CRSPCRISPR Therapeutics$56.22+1.0%3 of 5 stars2.35$73.93 31.5%17Gap Up0.41%ALKSAlkermes$24.15-1.3%5 of 5 stars2.50$35.38 46.5%10Positive News0.39%KRYSKrystal Biotech$164.10+0.2%5 of 5 stars3.00$171.00 4.2%9Short Interest ↑0.38%INSMInsmed$24.77-1.3%5 of 5 stars3.00$44.71 80.5%14Analyst ForecastInsider SellingShort Interest ↓Analyst RevisionNews Coverage0.37%BBIOBridgeBio Pharma$30.09-3.1%5 of 5 stars2.91$48.00 59.5%11Analyst ForecastShort Interest ↑News Coverage0.36%MDGLMadrigal Pharmaceuticals$220.06+1.3%4 of 5 stars2.73$345.09 56.8%11Insider Selling0.34%CRNXCrinetics Pharmaceuticals$51.40-1.0%4 of 5 stars2.92$58.42 13.7%12Analyst ForecastInsider SellingShort Interest ↓0.34%FTREFortrea$27.55-0.9%3 of 5 stars2.67$35.57 29.1%9Earnings ReportAnalyst UpgradeNews Coverage0.34%RAREUltragenyx Pharmaceutical$41.87-1.7%4 of 5 stars2.92$87.85 109.8%120.32%XENEXenon Pharmaceuticals$39.80-1.3%3 of 5 stars3.00$59.11 48.5%9Options Volume0.31%FOLDAmicus Therapeutics$9.57+0.7%4 of 5 stars2.86$17.50 82.9%7Analyst UpgradeShort Interest ↓0.30%ALPNAlpine Immune Sciences$64.97+0.0%2 of 5 stars2.27$52.33 -19.5%11Analyst ForecastNews CoveragePositive NewsHigh Trading Volume This page (NASDAQ:IBB) was last updated on 5/18/2024 by MarketBeat.com Staff From Our PartnersDems have chosen Biden replacement?Paradigm PressCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaCrypto Pioneer Says: “The last crypto bull market has begun.”InvestorPlaceI’m afraid WWIII is a very real possibility Porter & CompanyPOTUS in ‘25 Not Biden/Trump, ButThe Freeport SocietyMissed NVDA? Buy this AI stock NOWChaikin AnalyticsUrgent Nvidia WarningAltimetry Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding iShares Biotechnology ETF Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
